BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 18006777)

  • 1. Schisandrin B prevents doxorubicin-induced cardiotoxicity via enhancing glutathione redox cycling.
    Li L; Pan Q; Han W; Liu Z; Li L; Hu X
    Clin Cancer Res; 2007 Nov; 13(22 Pt 1):6753-60. PubMed ID: 18006777
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Schisandrin B prevents doxorubicin-induced chronic cardiotoxicity and enhances its anticancer activity in vivo.
    Xu Y; Liu Z; Sun J; Pan Q; Sun F; Yan Z; Hu X
    PLoS One; 2011; 6(12):e28335. PubMed ID: 22164272
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Prevention against and treatment of doxorubicin-induced acute cardiotoxicity by dexrazoxane and schisandrin B].
    Hu KY; Yang Y; He LH; Wang DW; Jia ZR; Li SR; Tian W; Mao J; Li XJ; Zhang W
    Yao Xue Xue Bao; 2014 Jul; 49(7):1007-12. PubMed ID: 25233631
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protective effect of schisandrin B against cyclosporine A-induced nephrotoxicity in vitro and in vivo.
    Zhu S; Wang Y; Chen M; Jin J; Qiu Y; Huang M; Huang Z
    Am J Chin Med; 2012; 40(3):551-66. PubMed ID: 22745070
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevention and treatment of doxorubicin-induced cardiotoxicity by dexrazoxane and schisandrin B in rabbits.
    Che F; Liu Y; Xu C
    Int J Toxicol; 2011 Dec; 30(6):681-9. PubMed ID: 21994238
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Schisandrin B prevents doxorubicin induced cardiac dysfunction by modulation of DNA damage, oxidative stress and inflammation through inhibition of MAPK/p53 signaling.
    Thandavarayan RA; Giridharan VV; Arumugam S; Suzuki K; Ko KM; Krishnamurthy P; Watanabe K; Konishi T
    PLoS One; 2015; 10(3):e0119214. PubMed ID: 25742619
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Doxorubicin mediated cardiotoxicity in rats: protective role of felodipine on cardiac indices.
    Gandhi H; Patel VB; Mistry N; Patni N; Nandania J; Balaraman R
    Environ Toxicol Pharmacol; 2013 Nov; 36(3):787-95. PubMed ID: 23958971
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preventive effects of ellagic acid against doxorubicin-induced cardio-toxicity in mice.
    Lin MC; Yin MC
    Cardiovasc Toxicol; 2013 Sep; 13(3):185-93. PubMed ID: 23322372
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ethanolic extract of Boswellia ovalifoliolata bark and leaf attenuates doxorubicin-induced cardiotoxicity in mice.
    Uma Mahesh B; Shrivastava S; Kuncha M; Sahu BD; Swamy CV; Pragada RR; Naidu VG; Sistla R
    Environ Toxicol Pharmacol; 2013 Nov; 36(3):840-9. PubMed ID: 23981374
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential effect of schisandrin B and dimethyl diphenyl bicarboxylate (DDB) on hepatic mitochondrial glutathione redox status in carbon tetrachloride intoxicated mice.
    Ip SP; Yiu HY; Ko KM
    Mol Cell Biochem; 2000 Feb; 205(1-2):111-4. PubMed ID: 10821428
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Schisandrin B enhances the glutathione redox cycling and protects against oxidant injury in different types of cultured cells.
    Lam PY; Leong PK; Chen N; Ko KM
    Biofactors; 2011; 37(6):439-46. PubMed ID: 22034285
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Schisandrin B protects against solar irradiation-induced oxidative stress in rat skin tissue.
    Lam PY; Yan CW; Chiu PY; Leung HY; Ko KM
    Fitoterapia; 2011 Apr; 82(3):393-400. PubMed ID: 21111034
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Methylenedioxy group and cyclooctadiene ring as structural determinants of schisandrin in protecting against myocardial ischemia-reperfusion injury in rats.
    Yim TK; Ko KM
    Biochem Pharmacol; 1999 Jan; 57(1):77-81. PubMed ID: 9920287
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Schisandrin B protects against solar irradiation-induced oxidative injury in BJ human fibroblasts.
    Chiu PY; Lam PY; Yan CW; Ko KM
    Fitoterapia; 2011 Jun; 82(4):682-91. PubMed ID: 21356279
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Schisandrin B prevents doxorubicin-induced cardiotoxicity in rabbits].
    Che FF; Liu Y; Xu CG
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2010 Jan; 41(1):24-8. PubMed ID: 20369464
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Loss of Mrp1 Potentiates Doxorubicin-Induced Cytotoxicity in Neonatal Mouse Cardiomyocytes and Cardiac Fibroblasts.
    Zhang W; St Clair D; Butterfield A; Vore M
    Toxicol Sci; 2016 May; 151(1):44-56. PubMed ID: 26822305
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel antioxidants in anthracycline cardiotoxicity.
    Hideg K; Kálai T
    Cardiovasc Toxicol; 2007; 7(2):160-4. PubMed ID: 17652823
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combination of schisandrin and nootkatone exerts neuroprotective effect in Alzheimer's disease mice model.
    Qi Y; Cheng X; Jing H; Yan T; Xiao F; Wu B; Bi K; Jia Y
    Metab Brain Dis; 2019 Dec; 34(6):1689-1703. PubMed ID: 31422511
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Schisandrin B protects against myocardial ischemia-reperfusion injury by enhancing myocardial glutathione antioxidant status.
    Yim TK; Ko KM
    Mol Cell Biochem; 1999 Jun; 196(1-2):151-6. PubMed ID: 10448914
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antioxidant defense against anthracycline cardiotoxicity by metallothionein.
    Kang YJ
    Cardiovasc Toxicol; 2007; 7(2):95-100. PubMed ID: 17652812
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.